Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update

Kwong Ming Fock, Nicholas J. Talley, Ronnie Fass, Khean Lee Goh, Peter Katelaris, Richard Hunt, Michio Hongo, Tiing Leong Ang, Gerald Holtmann, Sanjay Nandurkar, San Ren Lin, Benjamin C.Y. Wong, Francis K.L. Chan, Abdul Aziz Rani, Young-Tae Bak, Jose Sollano, Lawrence K.Y. Ho, Sathoporn Manatsathit

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Background and Aims: Since the publication of the Asia-Pacific GERD consensus in 2004, more data concerning the epidemiology and management of gastroesophageal reflux disease (GERD) have emerged. An evidence based review and update was needed. Methods: A multidisciplinary group developed consensus statements using the Delphi approach. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Results: GERD is increasing in frequency in Asia. Risk factors include older age, male sex, race, family history, higher socioeconomic status, increased body mass index, and smoking. Symptomatic response to a proton pump inhibitor (PPI) test is diagnostic in patients with typical symptoms if alarm symptoms are absent. A negative pH study off therapy excludes GERD if a PPI test fails. The role for narrow band imaging, capsule endoscopy, and wireless pH monitoring has not yet been undefined. Diagnostic strategies in Asia must consider coexistent gastric cancer and peptic ulcer. Weight loss and elevation of head of bed improve reflux symptoms. PPIs are the most effective medical treatment. On-demand therapy is appropriate for nonerosive reflux disease (NERD) patients. Patients with chronic cough, laryngitis, and typical GERD symptoms should be offered twice daily PPI therapy after excluding non-GERD etiologies. Fundoplication could be offered to GERD patients when an experienced surgeon is available. Endoscopic treatment of GERD should not be offered outside clinical trials. Conclusions: Further studies are needed to clarify the role of newer diagnostic modalities and endoscopic therapy. Diagnostic strategies for GERD in Asia must consider coexistent gastric cancer and peptic ulcer. PPIs remain the cornerstone of therapy.

Original languageEnglish
Pages (from-to)8-22
Number of pages15
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume23
Issue number1
DOIs
Publication statusPublished - 2008 Jan 1

Fingerprint

Gastroesophageal Reflux
Consensus
Proton Pump Inhibitors
Stomach Ulcer
Peptic Ulcer
Therapeutics
Stomach Neoplasms
Narrow Band Imaging
Laryngitis
Capsule Endoscopy
Fundoplication
Routine Diagnostic Tests
Cough
Social Class
Publications
Weight Loss
Epidemiology
Body Mass Index
Smoking
Clinical Trials

Keywords

  • Consensus
  • Erosive esophagitis
  • Non-erosive reflux disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Asia-Pacific consensus on the management of gastroesophageal reflux disease : Update. / Fock, Kwong Ming; Talley, Nicholas J.; Fass, Ronnie; Goh, Khean Lee; Katelaris, Peter; Hunt, Richard; Hongo, Michio; Ang, Tiing Leong; Holtmann, Gerald; Nandurkar, Sanjay; Lin, San Ren; Wong, Benjamin C.Y.; Chan, Francis K.L.; Rani, Abdul Aziz; Bak, Young-Tae; Sollano, Jose; Ho, Lawrence K.Y.; Manatsathit, Sathoporn.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 23, No. 1, 01.01.2008, p. 8-22.

Research output: Contribution to journalArticle

Fock, KM, Talley, NJ, Fass, R, Goh, KL, Katelaris, P, Hunt, R, Hongo, M, Ang, TL, Holtmann, G, Nandurkar, S, Lin, SR, Wong, BCY, Chan, FKL, Rani, AA, Bak, Y-T, Sollano, J, Ho, LKY & Manatsathit, S 2008, 'Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update', Journal of Gastroenterology and Hepatology (Australia), vol. 23, no. 1, pp. 8-22. https://doi.org/10.1111/j.1440-1746.2007.05249.x
Fock, Kwong Ming ; Talley, Nicholas J. ; Fass, Ronnie ; Goh, Khean Lee ; Katelaris, Peter ; Hunt, Richard ; Hongo, Michio ; Ang, Tiing Leong ; Holtmann, Gerald ; Nandurkar, Sanjay ; Lin, San Ren ; Wong, Benjamin C.Y. ; Chan, Francis K.L. ; Rani, Abdul Aziz ; Bak, Young-Tae ; Sollano, Jose ; Ho, Lawrence K.Y. ; Manatsathit, Sathoporn. / Asia-Pacific consensus on the management of gastroesophageal reflux disease : Update. In: Journal of Gastroenterology and Hepatology (Australia). 2008 ; Vol. 23, No. 1. pp. 8-22.
@article{d24909e7ee524f019603ade693681518,
title = "Asia-Pacific consensus on the management of gastroesophageal reflux disease: Update",
abstract = "Background and Aims: Since the publication of the Asia-Pacific GERD consensus in 2004, more data concerning the epidemiology and management of gastroesophageal reflux disease (GERD) have emerged. An evidence based review and update was needed. Methods: A multidisciplinary group developed consensus statements using the Delphi approach. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Results: GERD is increasing in frequency in Asia. Risk factors include older age, male sex, race, family history, higher socioeconomic status, increased body mass index, and smoking. Symptomatic response to a proton pump inhibitor (PPI) test is diagnostic in patients with typical symptoms if alarm symptoms are absent. A negative pH study off therapy excludes GERD if a PPI test fails. The role for narrow band imaging, capsule endoscopy, and wireless pH monitoring has not yet been undefined. Diagnostic strategies in Asia must consider coexistent gastric cancer and peptic ulcer. Weight loss and elevation of head of bed improve reflux symptoms. PPIs are the most effective medical treatment. On-demand therapy is appropriate for nonerosive reflux disease (NERD) patients. Patients with chronic cough, laryngitis, and typical GERD symptoms should be offered twice daily PPI therapy after excluding non-GERD etiologies. Fundoplication could be offered to GERD patients when an experienced surgeon is available. Endoscopic treatment of GERD should not be offered outside clinical trials. Conclusions: Further studies are needed to clarify the role of newer diagnostic modalities and endoscopic therapy. Diagnostic strategies for GERD in Asia must consider coexistent gastric cancer and peptic ulcer. PPIs remain the cornerstone of therapy.",
keywords = "Consensus, Erosive esophagitis, Non-erosive reflux disease",
author = "Fock, {Kwong Ming} and Talley, {Nicholas J.} and Ronnie Fass and Goh, {Khean Lee} and Peter Katelaris and Richard Hunt and Michio Hongo and Ang, {Tiing Leong} and Gerald Holtmann and Sanjay Nandurkar and Lin, {San Ren} and Wong, {Benjamin C.Y.} and Chan, {Francis K.L.} and Rani, {Abdul Aziz} and Young-Tae Bak and Jose Sollano and Ho, {Lawrence K.Y.} and Sathoporn Manatsathit",
year = "2008",
month = "1",
day = "1",
doi = "10.1111/j.1440-1746.2007.05249.x",
language = "English",
volume = "23",
pages = "8--22",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Asia-Pacific consensus on the management of gastroesophageal reflux disease

T2 - Update

AU - Fock, Kwong Ming

AU - Talley, Nicholas J.

AU - Fass, Ronnie

AU - Goh, Khean Lee

AU - Katelaris, Peter

AU - Hunt, Richard

AU - Hongo, Michio

AU - Ang, Tiing Leong

AU - Holtmann, Gerald

AU - Nandurkar, Sanjay

AU - Lin, San Ren

AU - Wong, Benjamin C.Y.

AU - Chan, Francis K.L.

AU - Rani, Abdul Aziz

AU - Bak, Young-Tae

AU - Sollano, Jose

AU - Ho, Lawrence K.Y.

AU - Manatsathit, Sathoporn

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Background and Aims: Since the publication of the Asia-Pacific GERD consensus in 2004, more data concerning the epidemiology and management of gastroesophageal reflux disease (GERD) have emerged. An evidence based review and update was needed. Methods: A multidisciplinary group developed consensus statements using the Delphi approach. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Results: GERD is increasing in frequency in Asia. Risk factors include older age, male sex, race, family history, higher socioeconomic status, increased body mass index, and smoking. Symptomatic response to a proton pump inhibitor (PPI) test is diagnostic in patients with typical symptoms if alarm symptoms are absent. A negative pH study off therapy excludes GERD if a PPI test fails. The role for narrow band imaging, capsule endoscopy, and wireless pH monitoring has not yet been undefined. Diagnostic strategies in Asia must consider coexistent gastric cancer and peptic ulcer. Weight loss and elevation of head of bed improve reflux symptoms. PPIs are the most effective medical treatment. On-demand therapy is appropriate for nonerosive reflux disease (NERD) patients. Patients with chronic cough, laryngitis, and typical GERD symptoms should be offered twice daily PPI therapy after excluding non-GERD etiologies. Fundoplication could be offered to GERD patients when an experienced surgeon is available. Endoscopic treatment of GERD should not be offered outside clinical trials. Conclusions: Further studies are needed to clarify the role of newer diagnostic modalities and endoscopic therapy. Diagnostic strategies for GERD in Asia must consider coexistent gastric cancer and peptic ulcer. PPIs remain the cornerstone of therapy.

AB - Background and Aims: Since the publication of the Asia-Pacific GERD consensus in 2004, more data concerning the epidemiology and management of gastroesophageal reflux disease (GERD) have emerged. An evidence based review and update was needed. Methods: A multidisciplinary group developed consensus statements using the Delphi approach. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Results: GERD is increasing in frequency in Asia. Risk factors include older age, male sex, race, family history, higher socioeconomic status, increased body mass index, and smoking. Symptomatic response to a proton pump inhibitor (PPI) test is diagnostic in patients with typical symptoms if alarm symptoms are absent. A negative pH study off therapy excludes GERD if a PPI test fails. The role for narrow band imaging, capsule endoscopy, and wireless pH monitoring has not yet been undefined. Diagnostic strategies in Asia must consider coexistent gastric cancer and peptic ulcer. Weight loss and elevation of head of bed improve reflux symptoms. PPIs are the most effective medical treatment. On-demand therapy is appropriate for nonerosive reflux disease (NERD) patients. Patients with chronic cough, laryngitis, and typical GERD symptoms should be offered twice daily PPI therapy after excluding non-GERD etiologies. Fundoplication could be offered to GERD patients when an experienced surgeon is available. Endoscopic treatment of GERD should not be offered outside clinical trials. Conclusions: Further studies are needed to clarify the role of newer diagnostic modalities and endoscopic therapy. Diagnostic strategies for GERD in Asia must consider coexistent gastric cancer and peptic ulcer. PPIs remain the cornerstone of therapy.

KW - Consensus

KW - Erosive esophagitis

KW - Non-erosive reflux disease

UR - http://www.scopus.com/inward/record.url?scp=37249000857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249000857&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2007.05249.x

DO - 10.1111/j.1440-1746.2007.05249.x

M3 - Article

C2 - 18171339

AN - SCOPUS:37249000857

VL - 23

SP - 8

EP - 22

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 1

ER -